NO20003786L - Oftalmisk sammensetning - Google Patents

Oftalmisk sammensetning

Info

Publication number
NO20003786L
NO20003786L NO20003786A NO20003786A NO20003786L NO 20003786 L NO20003786 L NO 20003786L NO 20003786 A NO20003786 A NO 20003786A NO 20003786 A NO20003786 A NO 20003786A NO 20003786 L NO20003786 L NO 20003786L
Authority
NO
Norway
Prior art keywords
treatment
corneal
ophthalmic composition
hypolacrimation
active ingredient
Prior art date
Application number
NO20003786A
Other languages
English (en)
Other versions
NO20003786D0 (no
Inventor
Ryuji Ueno
Ichie Kato
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO20003786L publication Critical patent/NO20003786L/no
Publication of NO20003786D0 publication Critical patent/NO20003786D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den oftalmiske sammensetningen ifølge denne oppfinnelsen anvendes for behandling av diabetisk hornhinnelesjon og/eller for behandling av forverret homhinneestesi som innbefatter, som en aktiv bestanddel, en forbindelse representert ved den generelle formelen (I): (D hvori A og B er uavhengig lavere alkylen, X, Y og Z er uavhengig halogen, eller et farmakologisk akseptabelt salt derav. I tillegg anvendes den oftalmiske sammensetningen ifølge denne oppfinnelsen for behandling av ikke-diabetisk hornhinnelesjon, for behandling av tørr-øye-syndrom og/eller for behandling av hypolakrimasjon som innbefatter, som en aktiv bestanddel, en aldose-reduktase-inhibitor. De oftalmiske sammensetningene ifølge denne oppfinnelsen er virksomme for behandling av minst en sykdom valgt blant hornhinnelesjon, forverret hornhinneestesi, tørr-øye- syndrom og hypolakrimasjon.
NO20003786A 1998-01-30 2000-07-24 Oftalmisk sammensetning NO20003786D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1983698 1998-01-30
PCT/JP1999/000369 WO1999038497A2 (en) 1998-01-30 1999-01-29 Ophthalmic composition

Publications (2)

Publication Number Publication Date
NO20003786L true NO20003786L (no) 2000-07-24
NO20003786D0 NO20003786D0 (no) 2000-07-24

Family

ID=12010371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003786A NO20003786D0 (no) 1998-01-30 2000-07-24 Oftalmisk sammensetning

Country Status (16)

Country Link
US (2) US6403598B1 (no)
EP (2) EP1161942A3 (no)
KR (1) KR20010040457A (no)
CN (1) CN1295476A (no)
AR (1) AR018272A1 (no)
AT (1) ATE223219T1 (no)
AU (1) AU2184499A (no)
BR (1) BR9907715A (no)
CA (1) CA2318516A1 (no)
DE (1) DE69902738T2 (no)
HU (1) HUP0100214A3 (no)
IL (1) IL137128A0 (no)
NO (1) NO20003786D0 (no)
TR (1) TR200002209T2 (no)
WO (1) WO1999038497A2 (no)
ZA (1) ZA99733B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043015A1 (fr) * 1999-01-25 2000-07-27 Fujisawa Pharmaceutical Co., Ltd. Gouttes ophtalmologiques
AU2001256855A1 (en) * 2000-05-08 2001-11-20 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
IL165910A0 (en) * 2002-07-03 2006-01-15 Pericor Science Inc Compositions of hyaluronic acid and methods of use
KR20070011497A (ko) * 2004-05-11 2007-01-24 산텐 세이야꾸 가부시키가이샤 각결막 장해 치료제
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
PE20070823A1 (es) * 2005-11-15 2007-08-09 Glaxo Group Ltd Sal tosilato de 8-(2,6-difluorofenil)-4-(4-fluoro-2-metilfenil)-2-{[2-hidroxi-1-(hidroximetil)etil]amino}pirido[2,3-]pirimidin-7(8h)-ona
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
WO2015095515A1 (en) * 2013-12-20 2015-06-25 Novartis Ag Sgc activators for the treatment of glaucoma
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
JP2020531511A (ja) * 2017-08-24 2020-11-05 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア 眼球用医薬組成物
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474967A (en) 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
JPS6143114A (ja) 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
GB8524663D0 (en) 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
JPH0782259A (ja) 1993-09-14 1995-03-28 Senju Pharmaceut Co Ltd スクシンアミド酸誘導体及びそれを含有する糖尿病合併症治療剤

Also Published As

Publication number Publication date
HUP0100214A2 (hu) 2002-02-28
US6403598B1 (en) 2002-06-11
WO1999038497A3 (en) 2000-03-09
CA2318516A1 (en) 1999-08-05
US6476039B1 (en) 2002-11-05
DE69902738D1 (de) 2002-10-10
EP1161942A3 (en) 2003-12-10
DE69902738T2 (de) 2003-02-06
CN1295476A (zh) 2001-05-16
WO1999038497A2 (en) 1999-08-05
KR20010040457A (ko) 2001-05-15
HUP0100214A3 (en) 2002-10-28
ZA99733B (en) 1999-08-02
AU2184499A (en) 1999-08-16
US20020161015A1 (en) 2002-10-31
IL137128A0 (en) 2001-07-24
TR200002209T2 (tr) 2000-11-21
AR018272A1 (es) 2001-11-14
ATE223219T1 (de) 2002-09-15
NO20003786D0 (no) 2000-07-24
EP1004307B1 (en) 2002-09-04
EP1161942A2 (en) 2001-12-12
BR9907715A (pt) 2000-10-17
EP1004307A2 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
NO20003786L (no) Oftalmisk sammensetning
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BRPI0408690A (pt) composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto
MX2007004783A (es) Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
PT1213296E (pt) Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao
BR0209468A (pt) Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
MXPA04009784A (es) Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas.
BR0213738A (pt) proteìnas morfogênicas ósseas (bmp), receptores de bmp e proteìnas de ligação de bmp e seu uso no diagnóstico e no tratamento de glaucoma
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
DK1414494T3 (da) Hæmmende antistoffer af HER3-aktivitet
NO20072286L (no) Hemming av HCV NS3-NS4A-protease
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
DK1780197T3 (da) 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer
BRPI0514661B8 (pt) antagonistas de vasopressina v1a, composição farmacêutica e uso dos referidos antagonistas
BR0310047A (pt) Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular
BR9811774A (pt) Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
EA200701780A1 (ru) Противоопухолевое средство
NO20045042L (no) 7-aryl -3,9-diazabicyklo (3.1.1)non-6-en-derivater og deres anvendelse som renin. inhibitorer ved behandling av hypertensjon, kardiovaskulaere og nyresykdommer
MX9802817A (es) Un agente para curar padecimientos oftalmologicos.
NO20032261L (no) Medisinske preparater
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
CN112469411B (zh) 供在由衰老细胞引起或介导的状况的临床管理中使用和用于治疗癌症的作为Bcl家族拮抗剂的氨基膦酸酯

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application